Paul Hetzel

Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc. is focused on specialty pharmaceuticals in dermatology and is a leading manufacturer of prescription and OTC medicines. Fougera is a Sandoz company, and part of the Novartis global network. Fougera has 273 associates working in the development and manufacturing of 65 unique product families and 147 unique SKU's. Our two facilities are located in Melville and Hicksville, New York. The company comprises of two divisions, Fougera - our generic division, and PharmaDerm our branded division, both producing prescription and OTC dermatologic medicines. Fougera has been serving the pharmaceutical industry for over 170 years, entering the generic market in 1966. With a rich U.S. history of experience and expertise, coupled with its modern technology and innovation, Fougera is poised to lead the way for important new generic introductions. We are steadfast in our mission to discover new ways to improve and extend people's lives and pioneer novel approaches to help people in the US access high-quality medicine. In addition to its leading generic business Fougera also has a well-respected branded dermatology business, PharmaDerm. PharmaDerm is dedicated to developing and commercializing prescription products to treat diseases and conditions of the skin — the largest organ of the human body. The company has in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. See www.pharmaderm.com for more information.